Get the Stockscreener App
2.975
9.30%
-0.305
Purple Biotech Ltd Adr stock is traded at $2.975, with a volume of 28,500.
It is down -9.30% in the last 24 hours and down -29.00% over the past month.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.
See More
Previous Close:
$3.28
Open:
$3.28
24h Volume:
28,500
Relative Volume:
0.03
Market Cap:
$8.47M
Revenue:
-
Net Income/Loss:
$-19.88M
P/E Ratio:
-3.2692
EPS:
-0.91
Net Cash Flow:
$-19.93M
1W Performance:
-8.46%
1M Performance:
-29.00%
6M Performance:
-59.99%
1Y Performance:
-81.17%
1-Day Range:
$2.8301
$3.28
1-Week Range:
$2.8301
$3.37
52-Week Range:
$2.00
$20.60
Purple Biotech Ltd Adr Stock (PPBT) Company Profile
Compare PPBT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PPBT
Purple Biotech Ltd Adr
|
2.95 | 8.47M | 0 | -19.88M | -19.93M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.10 | 123.91B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
716.63 | 78.94B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
652.98 | 39.98B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
275.32 | 35.89B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.92 | 28.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Purple Biotech Ltd Adr Stock (PPBT) Latest News
PPBT Stock Surges 150% on Superior Efficacy of PDAC Combo Therapy - Yahoo Finance
Why Purple Biotech (PPBT) Stock Is Getting Hammered - Benzinga
Purple Biotech Reports Third Quarter 2024 Financial Results - GlobeNewswire Inc.
Purple Biotech Reports Third Quarter 2024 Financial Results - Yahoo Finance
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.65% - MSN
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.65% - MSN
PPBT stock touches 52-week low at $3.52 amid market challenges - Investing.com India
PPBT stock touches 52-week low at $5.89 amid market challenges - Investing.com India
Purple Biotech price target raised by H.C. Wainwright, maintains Buy rating - Investing.com India
PPBT stock touches 52-week high at $8.02 amid market fluctuations - Investing.com
Ratio Review: Analyzing Purple Biotech Ltd ADR (PPBT)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
What Makes Purple Biotech (PPBT) a New Buy Stock - Yahoo Finance
Purple Biotech stock target cut on trial cohort issue - Investing.com
95 Promising Stocks You Can Currently Buy for Less Than $5 Per Share - GOBankingRates
Purple Biotech stock retains Buy rating from H.C. Wainwright - Investing.com
Why Purple Biotech (PPBT) Shares Are Trading Lower - Benzinga
Purple Biotech shares target cut by Jones Trading on interim Ph2 data - Investing.com
Here's Why Purple Biotech Ltd. Sponsored ADR (PPBT) Could be Great Choice for a Bottom Fisher - Yahoo Finance
Best Penny Stocks Under $1 To Buy Now - AOL
A new, genetically modified purple tomato may hit the grocery market stands - CNN
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts - Benzinga
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Markets Insider
Purple Biotech (PPBT) Stock Price, News & Analysis - MarketBeat
Market Data Center - Barron's
The FDA Just Approved Kitov's ConsensiNow What? (NASDAQ:PPBT) - Seeking Alpha
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
Purple Biotech Ltd Adr Stock (PPBT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):